What is Integrated Laboratory Systems?
Integrated Laboratory Systems, LLC operates as a contract research organization (CRO) dedicated to providing comprehensive research and testing services. Its client base spans the pharmaceutical, chemical, agrochemical, food additive, and consumer product industries, alongside federal government contracts. The company specializes in a wide array of scientific disciplines, including investigative toxicology, genetic toxicology, computational toxicology, histology, pathology, molecular biology, and information science. ILS offers a flexible and integrated service model, ensuring compliance with national and international regulatory standards to uphold the quality of its clients' products.
How much funding has Integrated Laboratory Systems raised?
Integrated Laboratory Systems has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Integrated Laboratory Systems
PPP
Public-Private Partnership
What's next for Integrated Laboratory Systems?
The substantial enterprise-level funding and recent strategic investment indicate a phase of significant growth and potential expansion for Integrated Laboratory Systems. This capital infusion is likely to fuel advancements in its research capabilities, potentially broadening its service offerings in toxicology and molecular biology, and strengthening its market position within the competitive CRO sector. The company's focus on regulatory compliance and diverse industry support suggests a strategic direction aimed at capturing a larger share of the pharmaceutical and chemical testing markets.
See full Integrated Laboratory Systems company page
